2026 Hot Hyperbaric Oxygen Chamber Hbot Exercise Rehabilitation Diabetic Foot Therapy

Name: 2026 Hot Hyperbaric Oxygen Chamber Hbot Exercise Rehabilitation Diabetic Foot Therapy
Brand: Nanjing Kingshare Biotechnology Co., Ltd.
SKU: 2277494635

Jiangsu, ChinaNanjing Kingshare Biotechnology Co., Ltd.

US$10,999.00-16,999.00

1 Set

Product profile

Customization

Available

Product Name

Hyperbaric Oxygen Chamber Hbot for Human

Application

Home Clinic Gym SPA Sport Diving Office

Model NO.

KX-YFL

Optional

TV,Bibs,Red Light Bed

Certificate

Ukca/CE/ISO/RoHS

Weight

1300kg

Pressure

2.0 ATA

Special Offer

Fresh Air System,Steel Door Handle

Flow Rate

15L

Oxygen Purity

93%

MOQ

Warranty

2 Years

Shelf Life

3 Years

Custom Made

Support

After Sale Service

Online Technical Support

Transport Package

Box/Pallet/Wooden Package

Specification

L2200*W1800*H1920mm

Trademark

Kingshare

Origin

China

Production Capacity

200 Suits/Year

Company profile

Standardized quality controlQuality AssuranceProduct CertificationFast Delivery

Nanjing Kingshare Biotechnology Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 3 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.43h

AI-Powered supplier vetting

SummaryKingShare Biotech is presented as a vertically integrated biotechnology solutions provider with more than 20 years of experience and its own manufacturing facility exceeding 5,000 square meters. It reports professional R&D capability, 3D software design, broad customization services, documented design controls, and technical support covering production and after-sales service. Production information includes annual output of 10,800 hyperbaric oxygen chamber sets, inventory capability, and standardized finished-product inspection instructions. However, only one QA/QC inspector is reported, and the supplier lacks overseas warehouses, showrooms, agents, or branches. Service-capability supplier management is weakly documented, with no written assessment procedures, approved-supplier list, or corrective/preventive-action records. Financial credibility cannot be favorably assessed because the provided financial data is zero-valued and incomplete. No certifications or customer cases are explicitly provided.

Supplier typeThe supplier identifies itself as a vertically integrated biotechnology solutions provider with its own manufacturing facility and global B2B sales models. Its stated business scope includes medical-device production and sales of separation, purification, and mechanical equipment, supporting classification as a manufacturer and technical solution supplier.

After-Sales capabilityTechnology engineers are responsible for technical support during production and after-sales service, indicating an internal after-sales support function. However, the supplier reports no overseas warehouse, showroom, agent, or branch capability, so overseas service coverage appears limited.

R&D capabilityThe supplier reports professional R&D capability, 3D software design, broad product-design services, technical engineers for new-product development, and available design input/output, review, verification, and validation documentation. No SDK is available, which limits software-development integration capability but does not negate the documented product R&D capability.

Production capacityThe supplier operates its own manufacturing facility exceeding 5,000 square meters, reports annual production of 10,800 hyperbaric oxygen chamber sets, and has in-stock service capability. Finished-product inspection follows documented and uniformly applied instructions, although only one QA/QC inspector is reported.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization, supported by engineers who confirm customer requirements and design new products. The availability of design-control documentation further supports structured customization execution.